Renovaro Selling And Marketing Expenses vs Total Operating Expenses Analysis

RENB Stock   0.69  0.08  12.95%   
Renovaro Biosciences financial indicator trend analysis is much more than just breaking down Renovaro Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Renovaro Biosciences is a good investment. Please check the relationship between Renovaro Biosciences Selling And Marketing Expenses and its Total Operating Expenses accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renovaro Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.

Selling And Marketing Expenses vs Total Operating Expenses

Selling And Marketing Expenses vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Renovaro Biosciences Selling And Marketing Expenses account and Total Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between Renovaro Biosciences' Selling And Marketing Expenses and Total Operating Expenses is -0.91. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Renovaro Biosciences, assuming nothing else is changed. The correlation between historical values of Renovaro Biosciences' Selling And Marketing Expenses and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Renovaro Biosciences are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Selling And Marketing Expenses i.e., Renovaro Biosciences' Selling And Marketing Expenses and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.91
Relationship DirectionNegative 
Relationship StrengthSignificant

Selling And Marketing Expenses

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from Renovaro Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Renovaro Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renovaro Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.The current year's Selling General Administrative is expected to grow to about 25.4 M, whereas Tax Provision is forecasted to decline to 0.00.

Renovaro Biosciences fundamental ratios Correlations

0.970.22-0.830.60.770.810.930.270.060.4-0.27-0.270.740.85-0.21-0.180.540.32-0.18-0.27-0.50.93-0.2-0.430.33
0.970.19-0.910.650.810.810.950.240.10.47-0.31-0.310.830.88-0.25-0.220.720.3-0.2-0.28-0.610.98-0.19-0.50.38
0.220.19-0.330.770.670.630.481.00.89-0.60.760.760.050.560.720.80.020.990.540.870.020.140.44-0.750.87
-0.83-0.91-0.33-0.83-0.91-0.8-0.92-0.37-0.37-0.370.110.11-0.91-0.940.130.02-0.82-0.420.180.070.58-0.890.130.74-0.64
0.60.650.77-0.830.970.840.830.790.8-0.110.410.410.620.920.340.480.570.810.170.49-0.320.60.2-0.960.92
0.770.810.67-0.910.970.920.940.710.650.030.230.230.720.980.210.310.630.740.10.31-0.440.770.09-0.880.83
0.810.810.63-0.80.840.920.910.680.54-0.040.220.220.640.890.360.30.510.710.180.25-0.590.770.11-0.680.68
0.930.950.48-0.920.830.940.910.520.380.24-0.03-0.030.770.97-0.010.060.650.57-0.030.03-0.520.92-0.05-0.70.62
0.270.241.0-0.370.790.710.680.520.89-0.570.740.740.10.590.710.780.061.00.530.84-0.040.190.43-0.760.89
0.060.10.89-0.370.80.650.540.380.89-0.550.790.790.160.520.720.810.190.880.50.87-0.040.050.55-0.840.91
0.40.47-0.6-0.37-0.110.03-0.040.24-0.57-0.55-0.89-0.890.50.2-0.81-0.880.5-0.52-0.75-0.79-0.420.52-0.450.09-0.3
-0.27-0.310.760.110.410.230.22-0.030.740.79-0.891.0-0.310.080.850.99-0.280.70.540.90.37-0.390.47-0.450.57
-0.27-0.310.760.110.410.230.22-0.030.740.79-0.891.0-0.310.080.850.99-0.280.70.540.90.37-0.390.47-0.450.57
0.740.830.05-0.910.620.720.640.770.10.160.5-0.31-0.310.77-0.26-0.230.80.14-0.25-0.29-0.660.82-0.18-0.550.41
0.850.880.56-0.940.920.980.890.970.590.520.20.080.080.770.050.160.680.63-0.050.15-0.450.840.01-0.840.74
-0.21-0.250.720.130.340.210.36-0.010.710.72-0.810.850.85-0.260.050.85-0.280.680.620.83-0.02-0.30.53-0.320.49
-0.18-0.220.80.020.480.310.30.060.780.81-0.880.990.99-0.230.160.85-0.220.740.530.890.32-0.30.46-0.510.62
0.540.720.02-0.820.570.630.510.650.060.190.5-0.28-0.280.80.68-0.28-0.220.09-0.27-0.24-0.620.75-0.01-0.540.4
0.320.30.99-0.420.810.740.710.571.00.88-0.520.70.70.140.630.680.740.090.510.81-0.080.240.41-0.770.89
-0.18-0.20.540.180.170.10.18-0.030.530.5-0.750.540.54-0.25-0.050.620.53-0.270.510.620.0-0.190.52-0.070.32
-0.27-0.280.870.070.490.310.250.030.840.87-0.790.90.9-0.290.150.830.89-0.240.810.620.25-0.310.54-0.550.68
-0.5-0.610.020.58-0.32-0.44-0.59-0.52-0.04-0.04-0.420.370.37-0.66-0.45-0.020.32-0.62-0.080.00.25-0.670.070.19-0.21
0.930.980.14-0.890.60.770.770.920.190.050.52-0.39-0.390.820.84-0.3-0.30.750.24-0.19-0.31-0.67-0.27-0.450.35
-0.2-0.190.440.130.20.090.11-0.050.430.55-0.450.470.47-0.180.010.530.46-0.010.410.520.540.07-0.27-0.230.31
-0.43-0.5-0.750.74-0.96-0.88-0.68-0.7-0.76-0.840.09-0.45-0.45-0.55-0.84-0.32-0.51-0.54-0.77-0.07-0.550.19-0.45-0.23-0.92
0.330.380.87-0.640.920.830.680.620.890.91-0.30.570.570.410.740.490.620.40.890.320.68-0.210.350.31-0.92
Click cells to compare fundamentals

Renovaro Biosciences Account Relationship Matchups

Renovaro Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Other Current Liab470.6K1.3M3.6M723.2K17.9M18.8M
Total Current Liabilities1.3M1.9M6.5M11.0M30.3M31.8M
Total Stockholder Equity166.3M174.7M72.6M46.5M132.0M78.5M
Retained Earnings(64.2M)(90.9M)(204.3M)(244.0M)(324.7M)(308.4M)
Common Stock Total Equity3.6K4.5K4.7K5.2K6.0K6.3K
Other Stockholder Equity230.5M265.6M277.0M290.6M456.8M479.7M
Total Liab11.8M14.9M12.0M11.8M31.2M32.7M
Common Stock4.7K5.2K5.3K6.4K15.5K16.3K
Total Assets178.1M189.6M84.6M58.3M163.1M88.6M
Net Debt(1.1M)(13.4M)(2.2M)3.7M3.6M3.7M
Cash8.7M20.7M9.2M1.9M220.5K209.4K
Cash And Short Term Investments8.7M20.7M9.2M1.9M220.5K209.4K
Net Receivables20.8K2.0K1.6K1.1M1.3M1.3M
Common Stock Shares Outstanding46.3M47.2M52.5M56.3M96.2M101.1M
Liabilities And Stockholders Equity178.1M189.6M84.6M58.3M163.1M88.6M
Non Current Liabilities Total10.5M13.1M5.6M775.6K842.4K800.3K
Total Current Assets8.9M20.9M9.6M2.6M2.0M1.9M
Short Term Debt271.3K292.4K1.5M5.0M2.9M3.1M
Non Current Assets Total169.2M168.7M75.1M55.7M161.1M96.5M
Non Currrent Assets Other137.6K21.0K68.6K21.7K19.8K18.9K
Accumulated Other Comprehensive Income(41.4K)(10.8K)(30.4K)(29.9K)(170.8K)(162.3K)
Intangible Assets154.9M154.9M61.6M42.7M30.0K28.5K
Net Tangible Assets(269.1K)8.1M(636.4K)(7.8M)(7.0M)(6.7M)
Accounts Payable592.9K320.6K1.4M5.3M9.4M9.9M
Other Current Assets242.9K232.9K393.0K690.9K668.9K362.8K
Other Liab22.9M5.7M3.2M6.0M5.4M6.0M
Capital Lease Obligations1.8M1.5M1.2M969.0K1.1M871.1K
Net Invested Capital172.1M180.4M78.4M51.1M46.0M43.7M
Property Plant And Equipment Gross2.5M2.2M2.1M1.9M2.2M1.5M
Non Current Liabilities Other22.9M5.7M3.2M6.0M5.4M6.0M
Net Working Capital7.6M19.0M3.1M(8.5M)(7.6M)(7.2M)
Property Plant Equipment2.5M2.2M1.7M1.4M1.6M1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Renovaro Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Renovaro Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Renovaro Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Renovaro Biosciences Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renovaro Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renovaro Biosciences. If investors know Renovaro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renovaro Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.98)
Return On Assets
(0.15)
Return On Equity
(0.90)
The market value of Renovaro Biosciences is measured differently than its book value, which is the value of Renovaro that is recorded on the company's balance sheet. Investors also form their own opinion of Renovaro Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Renovaro Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renovaro Biosciences' market value can be influenced by many factors that don't directly affect Renovaro Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renovaro Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Renovaro Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renovaro Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.